| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2823785 | Multiple Sclerosis and Related Disorders | 2016 | 8 Pages |
Abstract
Initiation of NZ therapy did not result in true cognitive improvement over one year. Presumably, the increased test performance in both MS groups was artificial and due to retest effects that were stronger in patients with lower baseline performance. Adequate control groups are essential when evaluating cognitive functioning in intervention trials among RRMS patients.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Genetics
Authors
M. Sundgren, Fredrik Piehl, Ã
ke Wahlin, Tom Brismar,